BOLTON, P., PICKLES, A., MURPHY, M. & RUTTER, M. (1998) ‘Autism, Affective and Other Disorders: Patterns of Familial Aggregation’ , Psychological Medicine2 (1): 67-80 .
2.
CHUGANI, D.C. (2002) ‘Role of Altered Brain Serotonin Mechanisms in Autism’, Molecular Psychiatry7(suppl. 2): 516-517 .
3.
COMI, A., ZIMMERMAN, A., FRYE, V., LAW, P. & PEEDEN, J. (1999) ‘Familial Clustering of Autoimmune Disorders and Evaluation of Medical Risk Factors in Autism’ , Journal of Child Neurology14 (6): 388-394 .
4.
D ’EUFEMIA, P., FINOCCHIARO, R., CELLI, M., MONTELEONE, D. & GIARDINI, O. (1995) ‘Low Serum Tryptophan to Large Amino Acids Ratio in Idiopathic Infantile Autism’ , Biomedicine and Pharmacotherapy49 (6): 288-292 .
5.
MATHEWS, H., LORENS, S. & CLANCY, J. (1996) ‘Effect of d-fenfluramine on the Local Immune Response to the Opportunistic Microbial Pathogen Candida Albicans’ , Behavioral Brain Research73 (1-2): 369-374 .
6.
MCLAUGHLIN, D., LUCEY, J. & DINAN, T. (1994) ‘Central Serotonergic Hyper- Responsivity in Late-Onset Alzheimer’s Disease’ , American Journal of Psychiatry151 (11): 1701-1703 .
7.
SINGH, V., MORE, T. & SINGH, S. (1997) ‘Hyperserotonemia and Serotonin Receptor Antibodies in Children with Autism but Not Mental Retardation’ , Biological Psychiatry41 (6): 753-755 .
